series-a
Stage
2018
Founded
3
Investors
About
Altoida develops digital biomarkers for neurological disease using augmented reality and machine learning, offering a tablet-based application to measure cognitive and motoric functions via multimodal digital biomarkers.
Explore Altoida's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.